OBI Pharma Capital Reinvestment Ratio
Latest as of June 2013:
0.12x
OBI Pharma capital reinvestment ratio. OBI Pharma (4174) has a Capital Reinvestment Ratio of 0.12x as of June 2013, meaning it reinvests 0% of its operating cash flow (NT$50.26 Million) in capital expenditures (NT$5.80 Million). Check OBI Pharma investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
NT$50.26 Million
TWD
Capital Expenditures
NT$5.80 Million
TWD
Data as of
Jun 2013
Most recent filing
OBI Pharma Capital Reinvestment Ratio by Year (None–None)
OBI Pharma capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see OBI Pharma operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow